{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:40:30Z","timestamp":1794555630266,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103639"],"award-info":[{"award-number":["P20GM103639"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-infiltrating nerves play critical roles in promoting tumor growth and progression; however, the mechanisms that drive tumor innervation remain unclear. Upon transformation, tumors recruit surrounding peripheral nerves into the tumor microenvironment (TME) to obtain their own innervation, a process called axonogenesis. While in vitro studies suggest tumor cell-derived neurotrophins, such as brain-derived neurotrophic factor (BDNF), drive axonogenesis, this has yet to be demonstrated in vivo. During wound healing, macrophages are the primary source of neurotrophins. Given the critical role of macrophages in breast cancer growth, we investigated whether these immune cells drive tumor axonogenesis in breast tumors in vivo. Syngeneic Py230 mouse triple-negative breast cancer (TNBC) cells were transplanted into intact mice and mice lacking immune-derived BDNF. Bone marrow-derived macrophages from either wild-type or immune-BDNF-deficient mice were transplanted into tumor-bearing recipients to determine if macrophage-derived BDNF was sufficient to restore tumor growth and innervation. We found that transplanted TNBC cannot grow in the absence of immune-derived BDNF, and that depletion of macrophages from the TME compromises tumor innervation. Remarkably, the introduction of wild-type macrophages restores tumor growth and innervation in mice lacking immune-derived BDNF, demonstrating that macrophages are both necessary and sufficient for tumor axonogenesis in vivo. In the absence of sensory tumor innervation, tumor growth was significantly reduced. Moreover, targeting BDNF signaling diminished TNBC growth and innervation. Our findings identify macrophages as the critical source of BDNF driving axonogenesis in breast cancer and suggest that selectively targeting BDNF signaling could provide a novel therapeutic strategy for treating TNBC through compromising tumor innervation.<\/jats:p>","DOI":"10.1038\/s41418-026-01796-5","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:32:15Z","timestamp":1783006335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Macrophage-secreted brain-derived neurotrophic factor promotes tumor growth in triple-negative breast cancer by inducing axonogenesis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5066-4011","authenticated-orcid":false,"given":"Jumana","family":"Abbadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameswari","family":"Velayutham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand C.","family":"Annan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Reza","family":"Nikpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz G. S.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob W.","family":"Farriester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-9686","authenticated-orcid":false,"given":"Jessica M.","family":"Reel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3792-7120","authenticated-orcid":false,"given":"Eric C.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Szulzewsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Birbrair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kar-Ming","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8030-3340","authenticated-orcid":false,"given":"Maureen A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"1796_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31:1154\u201362.","journal-title":"Nat Med"},{"key":"1796_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1796_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"1796_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6283796","volume":"2020","author":"R Wei","year":"2020","unstructured":"Wei R, Liu S, Zhang S, Min L, Zhu S. Cellular and extracellular components in tumor microenvironment and their application in early diagnosis of cancers. Anal Cell Pathol. 2020;2020:6283796.","journal-title":"Anal Cell Pathol"},{"key":"1796_CR5","doi-asserted-by":"crossref","unstructured":"Gysler SM, Drapkin R. Tumor innervation: peripheral nerves take control of the tumor microenvironment. J Clin Investig. 2021;131:e147276.","DOI":"10.1172\/JCI147276"},{"key":"1796_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s12672-025-02827-2","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Fan Y, Wang Q, Shu X, Lin J, Guo J, et al. Tumor-infiltrating nerves: unraveling the role of cancer neuroscience in tumorigenesis, disease progression, and emerging therapies. Discov Oncol. 2025;16:1209.","journal-title":"Discov Oncol"},{"key":"1796_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1101\/gad.352292.124","volume":"38","author":"EK Sloan","year":"2024","unstructured":"Sloan EK. Harnessing brain-body communication to understand cancer. Genes Dev. 2024;38:820\u20132.","journal-title":"Genes Dev"},{"key":"1796_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade4443","volume":"9","author":"AC Restaino","year":"2023","unstructured":"Restaino AC, Walz A, Vermeer SJ, Barr J, Kovacs A, Fettig RR, et al. Functional neuronal circuits promote disease progression in cancer. Sci Adv. 2023;9:eade4443.","journal-title":"Sci Adv"},{"key":"1796_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00485-z","volume":"8","author":"TT Le","year":"2022","unstructured":"Le TT, Payne SL, Buckwald MN, Hayes LA, Parker SR, Burge CB, et al. Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3. NPJ Breast Cancer. 2022;8:116.","journal-title":"NPJ Breast Cancer"},{"key":"1796_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood M, Ahmadi M, Eichwald T, Ahmadi A, Majdoubi A, Roversi K, et al. Nociceptor neurons affect cancer immunosurveillance. Nature. 2022;611:405\u201312.","journal-title":"Nature"},{"key":"1796_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, et al. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1236361.","journal-title":"Science"},{"key":"1796_CR12","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","volume":"75","author":"P Jobling","year":"2015","unstructured":"Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H. Nerve-cancer cell cross-talk: a novel promoter of tumor progression. Cancer Res. 2015;75:1777\u201381.","journal-title":"Cancer Res"},{"key":"1796_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.601738","volume":"8","author":"W Wang","year":"2020","unstructured":"Wang W, Li L, Chen N, Niu C, Li Z, Hu J, et al. Nerves in the tumor microenvironment: origin and effects. Front Cell Dev Biol. 2020;8:601738.","journal-title":"Front Cell Dev Biol"},{"key":"1796_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-20-2793","volume":"81","author":"DA Silverman","year":"2021","unstructured":"Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit M. Cancer-associated neurogenesis and nerve-cancer cross-talk. Cancer Res. 2021;81:1431\u201340.","journal-title":"Cancer Res"},{"key":"1796_CR15","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00432-022-04365-8","volume":"149","author":"M Malekan","year":"2023","unstructured":"Malekan M, Nezamabadi SS, Samami E, Mohebalizadeh M, Saghazadeh A, Rezaei N. BDNF and its signaling in cancer. J Cancer Res Clin Oncol. 2023;149:2621\u201336.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1796_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/imm.13581","volume":"168","author":"Q Yu","year":"2023","unstructured":"Yu Q, Wang Y, Yi G, Yang W, Chen K, Tan X, et al. BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis. Immunology. 2023;168:320\u201330.","journal-title":"Immunology"},{"key":"1796_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13046-025-03532-2","volume":"44","author":"G Di Pompo","year":"2025","unstructured":"Di Pompo G, Mitsiadis TA, Pagella P, Pasquarelli A, Bettini G, Sabattini S, et al. Mesenchymal stroma drives axonogenesis and nerve-induced aggressiveness in osteosarcoma. J Exp Clin Cancer Res. 2025;44:276.","journal-title":"J Exp Clin Cancer Res"},{"key":"1796_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1006\/mcne.2002.1185","volume":"21","author":"PE Batchelor","year":"2002","unstructured":"Batchelor PE, Porritt MJ, Martinello P, Parish CL, Liberatore GT, Donnan GA, et al. Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci. 2002;21:436\u201353.","journal-title":"Mol Cell Neurosci"},{"key":"1796_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2340\/00015555-2321","volume":"96","author":"M Ashrafi","year":"2016","unstructured":"Ashrafi M, Baguneid M, Bayat A. The role of neuromediators and innervation in cutaneous wound healing. Acta Derm Venereol. 2016;96:587\u201394.","journal-title":"Acta Derm Venereol"},{"key":"1796_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650\u20139.","journal-title":"N Engl J Med"},{"key":"1796_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114829","volume":"43","author":"S Schmid","year":"2024","unstructured":"Schmid S, Russell ZR, Yamashita AS, West ME, Parrish AG, Walker J, et al. ERK signaling promotes resistance to TRK kinase inhibition in NTRK fusion-driven glioma mouse models. Cell Rep. 2024;43:114829.","journal-title":"Cell Rep"},{"key":"1796_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198088","volume":"286","author":"H Abusalamah","year":"2020","unstructured":"Abusalamah H, Reel JM, Lupfer CR. Pyruvate affects inflammatory responses of macrophages during influenza A virus infection. Virus Res. 2020;286:198088.","journal-title":"Virus Res"},{"key":"1796_CR23","doi-asserted-by":"crossref","unstructured":"Attri KS, Mehla K, Singh PK. Evaluation of macrophage polarization in pancreatic cancer microenvironment under hypoxia. In: Huang LE, editor. Hypoxia: Methods and Protocols. New York: Springer New York; 2018. p. 265-76.","DOI":"10.1007\/978-1-4939-7665-2_23"},{"key":"1796_CR24","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u2013W14.","journal-title":"Nucleic Acids Res"},{"key":"1796_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5603\/NJO.2021.0011","volume":"71","author":"S Cie\u015bla","year":"2021","unstructured":"Cie\u015bla S, Wichtowski M, Po\u017aniak-Balicka R, Murawa D. The surgical anatomy of the mammary gland. Vascularisation, innervation, lymphatic drainage and the structure of the axillary fossa (part 2. Nowotw J Oncol. 2021;71:62\u20139.","journal-title":"Nowotw J Oncol"},{"key":"1796_CR26","doi-asserted-by":"publisher","first-page":"R264","DOI":"10.1152\/ajpregu.00687.2009","volume":"300","author":"K Burgi","year":"2011","unstructured":"Burgi K, Cavalleri MT, Alves AS, Britto LR, Antunes VR, Michelini LC. Tyrosine hydroxylase immunoreactivity as indicator of sympathetic activity: simultaneous evaluation in different tissues of hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2011;300:R264\u201371.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1796_CR27","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1523\/JNEUROSCI.21-16-06077.2001","volume":"21","author":"SC Benn","year":"2001","unstructured":"Benn SC, Costigan M, Tate S, Fitzgerald M, Woolf CJ. Developmental expression of the TTX-resistant voltage-gated sodium channels Nav1.8 (SNS) and Nav1.9 (SNS2) in primary sensory neurons. J Neurosci. 2001;21:6077\u201385.","journal-title":"J Neurosci"},{"key":"1796_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/350230a0","volume":"350","author":"C Hyman","year":"1991","unstructured":"Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350:230\u20132.","journal-title":"Nature"},{"key":"1796_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/374450a0","volume":"374","author":"A Acheson","year":"1995","unstructured":"Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 1995;374:450\u20133.","journal-title":"Nature"},{"key":"1796_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2008.04.043","volume":"1219","author":"WG Cho","year":"2008","unstructured":"Cho WG, Valtschanoff JG. Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints. Brain Res. 2008;1219:59\u201365.","journal-title":"Brain Res"},{"key":"1796_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00441-008-0634-4","volume":"333","author":"U Ernsberger","year":"2008","unstructured":"Ernsberger U. The role of GDNF family ligand signalling in the differentiation of sympathetic and dorsal root ganglion neurons. Cell Tissue Res. 2008;333:353\u201371.","journal-title":"Cell Tissue Res"},{"key":"1796_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/cr.2015.149","volume":"26","author":"CL Li","year":"2016","unstructured":"Li CL, Li KC, Wu D, Chen Y, Luo H, Zhao JR, et al. Somatosensory neuron types identified by high-coverage single-cell RNA-sequencing and functional heterogeneity. Cell Res. 2016;26:83\u2013102.","journal-title":"Cell Res"},{"key":"1796_CR33","doi-asserted-by":"crossref","unstructured":"Brown DC. Resiniferatoxin: the evolution of the \u201cMolecular Scalpel\u201d for chronic pain relief. Pharmaceuticals. 2016;9:47\u201358.","DOI":"10.3390\/ph9030047"},{"key":"1796_CR34","doi-asserted-by":"publisher","first-page":"11021","DOI":"10.1074\/jbc.M008392200","volume":"276","author":"Z Olah","year":"2001","unstructured":"Olah Z, Szabo T, Karai L, Hough C, Fields RD, Caudle RM, et al. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem. 2001;276:11021\u201330.","journal-title":"J Biol Chem"},{"key":"1796_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1760782","volume":"17","author":"C Ma","year":"2026","unstructured":"Ma C, Teoh HK, Zhao Y, Wang Y, Zhao J, Liu Y, et al. Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy. Front Immunol. 2026;17:1760782.","journal-title":"Front Immunol"},{"key":"1796_CR36","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3389\/fimmu.2019.02928","volume":"10","author":"J Steenbrugge","year":"2019","unstructured":"Steenbrugge J, Vander Elst N, Demeyere K, De Wever O, Sanders NN, Van Den Broeck W, et al. Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer. Front Immunol. 2019;10:2928.","journal-title":"Front Immunol"},{"key":"1796_CR37","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.7150\/jca.91944","volume":"15","author":"H Li","year":"2024","unstructured":"Li H, Miao YQ, Suo LP, Wang X, Mao YQ, Zhang XH, et al. CD206 modulates the role of M2 macrophages in the origin of metastatic tumors. J Cancer. 2024;15:1462\u201386.","journal-title":"J Cancer"},{"key":"1796_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.775649","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Li Y, Jin X, Liao Q, Chen Z, Peng H, et al. CD38: a significant regulator of macrophage function. Front Oncol. 2022;12:775649.","journal-title":"Front Oncol"},{"key":"1796_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16944-3","volume":"12","author":"N Kawamura","year":"2022","unstructured":"Kawamura N, Katsuura G, Yamada-Goto N, Nakama R, Kambe Y, Miyata A, et al. Brain fractalkine-CX3CR1 signalling is anti-obesity system as anorexigenic and anti-inflammatory actions in diet-induced obese mice. Sci Rep. 2022;12:12604.","journal-title":"Sci Rep"},{"key":"1796_CR40","first-page":"325","volume":"27","author":"M Wlodarczyk","year":"2024","unstructured":"Wlodarczyk M, Nowicka G. DNA damage, obesity and obesity-related health complications: what are new data telling us? Curr Opin Clin Nutr Metab Care. 2024;27:325\u201330.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1796_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1084\/jem.193.6.727","volume":"193","author":"EY Lin","year":"2001","unstructured":"Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001;193:727\u201340.","journal-title":"J Exp Med"},{"key":"1796_CR42","doi-asserted-by":"publisher","first-page":"50731","DOI":"10.18632\/oncotarget.14913","volume":"8","author":"EC Carron","year":"2017","unstructured":"Carron EC, Homra S, Rosenberg J, Coffelt SB, Kittrell F, Zhang Y, et al. Macrophages promote the progression of premalignant mammary lesions to invasive cancer. Oncotarget. 2017;8:50731\u201346.","journal-title":"Oncotarget"},{"key":"1796_CR43","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1158\/1078-0432.CCR-10-1890","volume":"17","author":"E Vanhecke","year":"2011","unstructured":"Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, et al. Brain-derived neurotrophic factor and neurotrophin-4\/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res. 2011;17:1741\u201352.","journal-title":"Clin Cancer Res"},{"key":"1796_CR44","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/s41388-019-0756-z","volume":"38","author":"MJ Contreras-Z\u00e1rate","year":"2019","unstructured":"Contreras-Z\u00e1rate MJ, Day NL, Ormond DR, Borges VF, Tobet S, Gril B, et al. Estradiol induces BDNF\/TrkB signaling in triple-negative breast cancer to promote brain metastases. Oncogene. 2019;38:4685\u201399.","journal-title":"Oncogene"},{"key":"1796_CR45","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1096\/fj.201903236R","volume":"34","author":"L Liu","year":"2020","unstructured":"Liu L, Dana R, Yin J. Sensory neurons directly promote angiogenesis in response to inflammation via substance P signaling. FASEB J. 2020;34:6229\u201343.","journal-title":"FASEB J"},{"key":"1796_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70138","volume":"30","author":"M Lei","year":"2024","unstructured":"Lei M, Liu Q, Nie J, Huang R, Mei Y, Pan D, et al. Impact and mechanisms of action of BDNF on neurological disorders, cancer, and cardiovascular diseases. CNS Neurosci Ther. 2024;30:e70138.","journal-title":"CNS Neurosci Ther"},{"key":"1796_CR47","doi-asserted-by":"crossref","unstructured":"Ali SR, Jordan M, Nagarajan P, Amit M. Nerve density and neuronal biomarkers in cancer. Cancers. 2022;14:4817\u201332.","DOI":"10.3390\/cancers14194817"},{"key":"1796_CR48","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1101\/gad.841400","volume":"14","author":"M Bibel","year":"2000","unstructured":"Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14:2919\u201337.","journal-title":"Genes Dev"},{"key":"1796_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tcm.2007.03.002","volume":"17","author":"P Kermani","year":"2007","unstructured":"Kermani P, Hempstead B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc Med. 2007;17:140\u20133.","journal-title":"Trends Cardiovasc Med"},{"key":"1796_CR50","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1182\/blood-2004-08-3096","volume":"105","author":"RN Pearse","year":"2005","unstructured":"Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL. A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood. 2005;105:4429\u201336.","journal-title":"Blood"},{"key":"1796_CR51","doi-asserted-by":"publisher","first-page":"e0178173","DOI":"10.1371\/journal.pone.0178173","volume":"12","author":"YF Tsai","year":"2017","unstructured":"Tsai YF, Tseng LM, Hsu CY, Yang MH, Chiu JH, Shyr YM. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple-negative breast cancer. PLoS One. 2017;12:e0178173.","journal-title":"PLoS One"},{"key":"1796_CR52","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10571-015-0182-x","volume":"35","author":"XC Ji","year":"2015","unstructured":"Ji XC, Dang YY, Gao HY, Wang ZT, Gao M, Yang Y, et al. Local injection of Lenti-BDNF at the lesion site promotes m2 macrophage polarization and inhibits inflammatory response after spinal cord injury in mice. Cell Mol Neurobiol. 2015;35:881\u201390.","journal-title":"Cell Mol Neurobiol"},{"key":"1796_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155556","volume":"144","author":"NY Yap","year":"2021","unstructured":"Yap NY, Toh YL, Tan CJ, Acharya MM, Chan A. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment. Cytokine. 2021;144:155556.","journal-title":"Cytokine"},{"key":"1796_CR54","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-21-0465","volume":"27","author":"TW Laetsch","year":"2021","unstructured":"Laetsch TW, Hong DS. Tropomyosin receptor kinase inhibitors for the treatment of TRK fusion cancer. Clin Cancer Res. 2021;27:4974\u201382.","journal-title":"Clin Cancer Res"},{"key":"1796_CR55","doi-asserted-by":"publisher","first-page":"25225","DOI":"10.18632\/oncotarget.25396","volume":"9","author":"K Moriwaki","year":"2018","unstructured":"Moriwaki K, Ayani Y, Kuwabara H, Terada T, Kawata R, Asahi M. TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma. Oncotarget. 2018;9:25225\u201343.","journal-title":"Oncotarget"},{"key":"1796_CR56","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1021\/acs.jmedchem.6b00064","volume":"59","author":"M Menichincheri","year":"2016","unstructured":"Menichincheri M, Ardini E, Magnaghi P, Avanzi N, Banfi P, Bossi R, et al. Discovery of entrectinib: A new 3-aminoindazole as a potent anaplastic lymphoma kinase (ALK), c-ros oncogene 1 kinase (ROS1), and pan-tropomyosin receptor kinases (Pan-TRKs) inhibitor. J Med Chem. 2016;59:3392\u2013408.","journal-title":"J Med Chem"},{"key":"1796_CR57","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2147\/TCRM.S147381","volume":"14","author":"D Liu","year":"2018","unstructured":"Liu D, Offin M, Harnicar S, Li BT, Drilon A. Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors. Ther Clin Risk Manag. 2018;14:1247\u201352.","journal-title":"Ther Clin Risk Manag"},{"key":"1796_CR58","first-page":"2031","volume":"17","author":"L Meng","year":"2019","unstructured":"Meng L, Liu B, Ji R, Jiang X, Yan X, Xin Y. Targeting the BDNF\/TrkB pathway for the treatment of tumors. Oncol Lett. 2019;17:2031\u20139.","journal-title":"Oncol Lett"},{"key":"1796_CR59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731\u201347.","journal-title":"Nat Rev Clin Oncol"},{"key":"1796_CR60","doi-asserted-by":"publisher","first-page":"e9777","DOI":"10.1371\/journal.pone.0009777","volume":"5","author":"M Cazorla","year":"2010","unstructured":"Cazorla M, Jouvenceau A, Rose C, Guilloux JP, Pilon C, Dranovsky A, et al. Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice. PLoS One. 2010;5:e9777.","journal-title":"PLoS One"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01796-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01796-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:20:53Z","timestamp":1783012853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01796-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":60,"alternative-id":["1796"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01796-5","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}